Scaling internationally whilst protecting IP.
Qkine produce high-purity proteins for stem cell and regenerative medicine. Its platform supports bioscience R&D and manufacturing worldwide. By producing proteins of exceptional purity, that consistently meet high quality standards, Qkine ensures scientists get repeatable and reliable results, helping them move research forward faster and with greater confidence. As part of their scaling journey Qkine required support to strengthen its IP position, prepare for international expansion and build the foundations for rapid commercial growth.
Inventya provided strategic support around
IP Strategy
International Market Entry
Funding & Grant Support
Innovation Commercialisation
Impact
- Qkine has increased turnover by around 150%
- Expanded its international reach from 23 to 35 countries
- Grew the customer base by 400%
- Tripled the size of their team
Testimonial
Overall, the Scaleup Programme has been a catalyst for progress, helping us strengthen our innovation pipeline and position our business for long-term impact. It has given us the clarity and confidence to take bold next steps in our growth journey.